Atlas Trials

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Clinical trial NCT01203722 · COMPLETED

Trial details

NCT number
NCT01203722
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic Malignancies
Start date
2010-09-01
Primary completion
2024-05-28
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.